Clinical Trial Update: Real-life Evaluation of WEGOVY (Semaglutide) Treatment in Adults With Monogenic Obesity (ObGeSema)

View source ↗

Summary

A real-life evaluation study of Wegovy (semaglutide) in adults with monogenic obesity is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monogenic Obesity

Drugs mentioned

• WEGOVY (Semaglutide)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Monogenic Obesity | Status: RECRUITING